This inventor holds 1 USPTO granted patent. Top assignee: Shenyang Pharmaceutical University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Erfang Huang: Innovator in Estrogen Receptor Modulation
Introduction
Erfang Huang is a notable inventor based in Shenyang, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate estrogen receptors. His work is essential for advancing therapeutic options in various medical conditions.
Latest Patents
Erfang Huang holds 1 patent for his invention titled "Furo[3,2-g]chromene compounds and uses thereof." This patent discloses furo[3,2-g]chromene derivatives represented by a specific formula, including stereoisomers, pharmaceutically acceptable salts, and pharmaceutical compositions. The compounds are recognized for their potential uses as estrogen receptor modulators, which can have significant implications in treating hormone-related disorders.
Career Highlights
Erfang Huang is affiliated with Shenyang Pharmaceutical University, where he contributes to research and development in pharmaceutical sciences. His academic and professional journey reflects a commitment to innovation and excellence in his field.
Collaborations
Erfang Huang has worked alongside notable colleagues, including Xiaoping Liu and Chun Hu. Their collaborative efforts enhance the research output and innovation within their institution.
Conclusion
Erfang Huang's contributions to the field of estrogen receptor modulation through his patented compounds highlight his role as an influential inventor. His work continues to pave the way for advancements in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile